These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4287550)

  • 21. [On the therapy of myasthenia gravis. (Presentation of a case)].
    Henriquet F; Balestra L
    Minerva Anestesiol; 1970 Apr; 36(4):277-81. PubMed ID: 4320560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of subacute administration of discrete doses of ACTH in medium grade myasthenia. (Serial electromyographic study)].
    Pinelli P
    Riv Neurol; 1967; 37(4):343-65. PubMed ID: 4295653
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of ocular myasthenia with corticotrophin.
    Gibberd FB; Navab F; Smith CL
    J Neurol Neurosurg Psychiatry; 1971 Feb; 34(1):11-3. PubMed ID: 4323972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticotropin therapy in myasthenia gravis: effects, indications, and limitations.
    Namba T; Brunner NG; Shapiro MS; Grob D
    Neurology; 1971 Oct; 21(10):1008-18. PubMed ID: 4329627
    [No Abstract]   [Full Text] [Related]  

  • 27. Myasthenia gravis.
    Lott RS
    J Am Pharm Assoc; 1973 Aug; 13(8):444-50. PubMed ID: 4354762
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thymectomy in the management of myasthenia].
    Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
    Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrence of nonneoplastic thymus after thymectomy for myasthenia gravis. Report of two cases.
    Joseph BS; Johns TR
    Neurology; 1973 Feb; 23(2):109-16. PubMed ID: 4347062
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical and surgical treatment for ocular myasthenia.
    Benatar M; Kaminski H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of the clinical response to ACTH treatment with the endocrine status in myasthenia gravis.
    Cape CA; Arbona NJ
    South Med J; 1973 Sep; 66(9):1011-3. PubMed ID: 4354772
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
    Ricken D
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
    [No Abstract]   [Full Text] [Related]  

  • 35. [The Grob test in myasthenia: discussion of an atypical case].
    Gambi D; Tonali P
    Riv Neurol; 1971; 41(3):161-9. PubMed ID: 4331238
    [No Abstract]   [Full Text] [Related]  

  • 36. Crisis, precrisis and drug resistance in myasthenia gravis.
    Glaser GH
    Ann N Y Acad Sci; 1966 Jan; 135(1):335-49. PubMed ID: 5221348
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of myasthenia gravis].
    Igata A
    Naika; 1970 Apr; 25(4):676-82. PubMed ID: 5423420
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the relationship between negative effects and positive effects of ACTH therapy in myasthenic patients].
    Pinelli P; Gandiglio G
    Riv Neurol; 1968; 38(2):77-84. PubMed ID: 4298338
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with ACTH in the myasthenic syndrome with an immunological substratum].
    Radu H; Roşu AM; Lenkei R; Ionescu V; Darko Z
    Neurol Psihiatr Neurochir; 1973; 18(4):377-84. PubMed ID: 4356514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.